Research
Regrowth of Human Beta Cells for T1D and T2D
January 3, 2019
Regrowth of Human Beta Cells for T1D and T2D
Effective Therapeutic Rate A combination of two drugs enhances the production of beta cells such that they proliferate at the highest rate ever observed in humans – a rate of 5 to 8 percent per day. “Beta cell regeneration is…
Understanding Pancreas Cell Development
December 18, 2018
Understanding Pancreas Cell Development
Prof. Dr. Henrik Semb who led the study explains his recent paper in Nature. Dr. Semb and his team have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they are very…
Seraxis Islet Technology Aims for Practical T1D Cure
December 13, 2018
Seraxis Islet Technology Aims for Practical T1D Cure
Islet transplants offer the hope of a permanent cure for Type 1 Diabetes. After nearly six years in stealth mode, Seraxis has emerged as a front-runner in the race to clinical islet deployment. Privately funded, and without any NIH or…
Leveraging T2D Drugs to improve T1D Therapy
November 27, 2018
Leveraging T2D Drugs to improve T1D Therapy
Paresh Dandona, MD, Ph.D. (bio) has been passionate about blood sugar control since he became a Fellow in London in 1975. He joined the faculty of the University of Buffalo School of Medicine in 1995 and has a remarkable track…
Pramlintide Reimagined and Results are Promising
November 15, 2018
Pramlintide Reimagined and Results are Promising
Over a decade ago, the US approval and launch of pramlintide (Symlin® AstraZeneca) brought a lot of excitement because of its therapeutic ability, when used in combination with mealtime insulin, to flatten post-meal blood glucose levels, reduce glucose excursions, and…
Could bacteria be causing diabetes?
November 6, 2018
Could bacteria be causing diabetes?
The relationship between gut bacteria, genetics, and T1D risk is a complicated picture, but multiple studies indicate that gut bacteria is an essential factor. TEDDY The Environmental Determinants of Diabetes in the Young (TEDDY) is on ongoing, multi-study effort that…
Metformin May Improve Vascular Health in T1D Adolescents
November 2, 2018
Metformin May Improve Vascular Health in T1D Adolescents
Cardio vascular disease is the leading cause of mortality in people with T1D. This relates strongly to insulin resistance and both lean and obese T1D adolescents have marked insulin resistance. Metformin is known to improve surrogate markers of insulin resistance…
Update on Inhaled Insulin
November 1, 2018
Update on Inhaled Insulin
Rapid-acting insulins such as Novolog and Humalog often show peak insulin levels up to 3 hours after injection. In this period, glucose levels may fluctuate considerably. Inhaled insulin starts working more quickly and peaks in less than one hour. Diabetes…
Race to introduce a T1D drug that inhibits glucose absorption
October 25, 2018
Race to introduce a T1D drug that inhibits glucose absorption
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, also called gliflozin drugs, are a new class of diabetic medications. They work by reducing the re-absorption of glucose into the blood via the kidneys with the excess glucose urinated. The FDA has already approved…
Insulin could be a Possible New Therapy for Colitis
October 18, 2018
Insulin could be a Possible New Therapy for Colitis
Insulin is widely used to treat diabetes, and it may be beneficial in treating other conditions.
Maternal Gluten Intake Linked to T1D in Children
October 2, 2018
Maternal Gluten Intake Linked to T1D in Children
A study in Denmark covering more than 67,000 pregnancies mothers has revealed that mothers that consumed 20 g/day of gluten had double the risk of T1D development in their offspring!
New predictors are a lifeline for families living with Type 1 Diabetes
September 27, 2018
New predictors are a lifeline for families living with Type 1 Diabetes
Combining genetic testing with existing NIH TrialNet procedures has shown very positive initial results in predicting T1D.*
New Type 1 Therapy Promises Long-term Diabetes Reversal in Humans and Dogs
September 18, 2018
New Type 1 Therapy Promises Long-term Diabetes Reversal in Humans and Dogs
Preclinical animal study shows initial results on the first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days.
JDRF To Help Study Hypoglycemia
May 1, 2018
JDRF To Help Study Hypoglycemia
JDRF announces plans to participate in Hypo-RESOLVE research project.
Diabetes as a Disability in the Workplace
April 25, 2018
Diabetes as a Disability in the Workplace
An expert clarifies the laws that impact diabetes in the workplace.
How to Evaluate Diets and Supplements
April 23, 2018
How to Evaluate Diets and Supplements
A nutrition expert offers tips for thinking critically about health and weight loss claims.
Country Music Star Says She Was Harassed for Diabetic Service Dog
April 13, 2018
Country Music Star Says She Was Harassed for Diabetic Service Dog
RaeLynn was on her way to a diabetes conference when she encountered a suspicious flight attendant.
Mini-Glucagon With Alcohol?
April 12, 2018
Mini-Glucagon With Alcohol?
Danish study suggests that a low dose of glucagon may help T1Ds prone to hypoglycemia after alcohol.
CDC Report Understates Link Between DKA and Insulin Costs
April 11, 2018
CDC Report Understates Link Between DKA and Insulin Costs
A recent CDC report understates the relationship between DKA incidence and rising drug costs.
Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback?
April 9, 2018
Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback?
Kaiser Health News explores conflicts of interest among patient advocacy groups.